CELL rings, INTC trades widely, ICGN takes breather

Brightpoint Inc. (Nasdaq: CELL) shares moved north 32 percent Thursday to $12.57, on volumes of nearly three million, six times its full-day average, a day after presenting Q4 earnings that beat Street estimates.

Intel Inc. (Nasdaq: INTC) traded in 27.3 million shares Thursday, trailing its all-day average of 55.5 million. Shares for the chipmaker nosed ahead 0.6 percent to $21.50.

Icagen Inc. (Nasdaq: ICGN) got thumped 12.6 percent in price to $3.25 Thursday. Volume was 809,218, besting its daily average of 563,036, after the FDA lifted its hold on ICGN’s epilepsy drug.

Tags: buzz stocks, CELL, consumer discretionary, healthcare, ICGN, INTC, nasdaq, Technology Stocks

This entry was posted on Thursday, February 3rd, 2011 at 3:57 pm by Glenn and is filed under Consumer Discretionary Stocks, Health Care Stocks, Technology Stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.